Licheng Zhang

Virus‐Mimic mRNA Vaccine for Cancer Treatment

Haifa Shen, J. Mai, Shu-Hsia Chen, 2021, Advanced therapeutics.

Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis

V. Singh, C. Jagannath, Shu-Hsia Chen, 2022, Frontiers in Immunology.

A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer

Jenny C. Chang, L. Venta, W. Qian, 2021, Science Translational Medicine.

Chemotherapy coupled to macrophage inhibition induces T-cell and B-cell infiltration and durable regression in triple-negative breast cancer.

Jeffrey T. Chang, C. Perou, Zhandong Liu, 2022, Cancer research.

Chemotherapy coupled to macrophage inhibition leads to enhanced T and B cell infiltration and durable triple negative breast cancer regression

Jeffrey T. Chang, C. Perou, Zhandong Liu, 2021, bioRxiv.

A heparan-sulfate-bearing syndecan-1 glycoform is a distinct surface marker for intra-tumoral myeloid-derived suppressor cells

Haifa Shen, J. Mai, Guodong Zhang, 2021, iScience.

Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell Profiles

C. Coarfa, Shu-Hsia Chen, Yitian Xu, 2022, Cancer research communications.

Potentiating anti-tumor efficacy through radiation and sustained intratumoral delivery of anti-CD40 and anti-PDL1.

E. B. Butler, S. Demaria, A. Grattoni, 2020, International journal of radiation oncology, biology, physics.

A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer

E. B. Butler, J. Mejia, Jenny C. Chang, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

CAN-21-3714 2281..2297

Jeffrey T. Chang, C. Perou, Zhandong Liu, 2022 .